DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Lück HJ, Thomssen C, Untch M. et al.
Multicentric Phase III Study in first line treatment of advanced metastatic breast cancer (ABC). Epirubicin/Paclitaxel (ET) vs Epirubicin/Cyclophosphamide (EC). A study of the Ago Breast Cancer Group (abstr).
Proc Am Soc Clin Oncol 2000; 19: 280-280
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.